Federated Hermes
RVMD icon

Federated Hermes’s Revolution Medicines RVMD Stock Holding History

Federated Hermes’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17M Buy
+90,878
New +$13.3M 0.02% 540
2023
Q4 		– Sell
-4,547
Closed -$126K – 2184
2023
Q3 		$126K Buy
+4,547
New +$135K ﹤0.01% 1577
2021
Q1 		– Sell
-21,933
Closed -$868K – 2335
2020
Q4 		$868K Buy
+21,933
New +$867K ﹤0.01% 1374

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Federated Hermes's RVMD Position: Q2 2026 in Review

Federated Hermes opened a new position in Revolution Medicines (RVMD) in Q2 2026: 90,878 shares worth $17M. The stake represents 0.02% of the portfolio and ranks #540 among its holdings. This is a return to the name: Federated Hermes previously reported a position in RVMD as recently as Q3 2023.

Federated Hermes first reported a position in RVMD in Q4 2020 and has held it in 3 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Federated Hermes held 90,878 shares of Revolution Medicines worth $17M as of Q2 2026.
  • Revolution Medicines was a new Federated Hermes position in Q2 2026.
  • Revolution Medicines made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #540 holding.
  • Federated Hermes first reported a position in Revolution Medicines in Q4 2020 and has held it in 3 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.